BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kinoshita T, Shinoda M, Nishizaki Y, Shiraki K, Hirai Y, Kichikawa Y, Tsushima K, Sinkai M, Komura N, Yoshida K, Kido Y, Kakeya H, Uemura N, Kadota J. Phase 3, multicentre, double-blind, randomised, parallel-group, placebo-controlled study of camostat mesilate (FOY-305) for the treatment of COVID-19 (CANDLE study).. [DOI: 10.1101/2022.03.27.22271988] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Li J, Xue Y, Wang X, Smith LS, He B, Liu S, Zhu HJ. Tissue- and cell-expression of druggable host proteins provide insights into repurposing drugs for COVID-19. Clin Transl Sci 2022;15:2796-811. [PMID: 36259251 DOI: 10.1111/cts.13400] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]